Emcure Pharma Anil Kothiyal to resign as President - India Sales & Marketing
Advertisement
Pune: Emcure Pharmaceuticals Limited has announced the resignation of Anil Kothiyal, President - India Sales & Marketing and Senior Management Personnel of the Company effective from close of business hours on June 06, 2025, due to personal reasons.
"We would like to inform that Mr. Anil Kothiyal, President – India Sales & Marketing and Senior Management Personnel (“SMP”) of the Company, as per Regulation 16(1)(d) of SEBI Listing Regulations, vide his letter dated June 03, 2025, has submitted his resignation to be effective from close of business hours on June 06, 2025, on account of personal reasons," Emcure stated in a BSE filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.